Contact with venomous snakes and lizards

VWXY20_CONTACT_W_VENOMO_SNAKES_LIZAR

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — X20 Cause of death: ICD-10 — X20 2 out of 7 registries used, show all original rules.	394
4. Check minimum number of events None	394
5. Include endpoints None	394
6. Filter based on genotype QC (FinnGen only)	384

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 5
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: X20-X29

NAME	VWXY20_CONTACT_W_VENOMO_SNAKES_LIZAR
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	X20
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	X20
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Contact with venomous snakes and lizards based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	384	218	166
Unadjusted period prevalence (%)	0.08	0.08	0.08
Median age at first event (years)	52.51	50.01	55.79

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
394: Matched controls
3940

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

X20

ICD-10 Finland

Contact with venomous snakes and lizards

+∞

307.7

389

T63.0

ICD-10 Finland

Toxic effect: Snake venom

4356.0

307.7

331

S13

ICPC

Animal/human bite

5.5

14.1

C01CA24

ATC

epinephrine; parenteral

3.1

9.8

150

T63.9

ICD-10 Finland

Toxic effect: Toxic effect of contact with unspecified venomous animal

+∞

7.3

H02AB06

ATC

prednisolone; systemic

1.7

6.1

180

1308

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

141

885

1.92

8.36

2.2

145.16

298.02

u/l

1.22

134

837

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

365

1.94

5.15

4.2

4.5

35.05

31.54

1.59

245

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

160

1174

1.61

4.92

3.5

18.42

33.66

ng/l

2.26

107

803

(3019225) pH of Specimen

281

1.89

3.95

2.7

4.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

357

3267

1.99

3.95

12.2

13.2

15.85

23.38

mg/l

7.00

287

2522

(3002032) Base excess in Venous blood by calculation

279

1.86

3.72

2.2

4.5

1.67

1.97

mmol/l

0.37

224

(3022217) INR in Platelet poor plasma by Coagulation assay

179

1411

1.49

3.71

12.0

12.5

1.22

1.25

inr

0.14

454

(3019550) Sodium [Moles/volume] in Serum or Plasma

358

3295

1.95

3.65

13.3

15.1

139.90

139.66

mmol/l

1.19

350

3207

(40761511) CBC panel - Blood by Automated count

368

3447

2.02

3.12

11.4

12.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

356

3302

1.81

3.08

13.5

15.2

3.97

3.96

mmol/l

0.30

347

3207

(3006462) Nitrate [Presence] in Urine

5.92

3.03

1.4

1.7

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

5.46

2.88

2.9

2.7

66314.29

34831.15

ug/l

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

278

2459

1.44

2.77

4.2

3.8

14.57

14.74

pmol/l

0.59

259

2202

(3013826) Glucose [Moles/volume] in Serum or Plasma

220

1868

1.40

2.77

3.6

4.9

6.37

6.63

mmol/l

1.15

206

1727

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

368

3468

1.93

2.73

9.7

9.9

25.40

26.65

u/l

0.48

354

3345

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

168

1372

1.39

2.62

4.6

6.6

1.22

mmol/l

0.10

150

1256

(3037467) Urinalysis macro (dipstick) panel - Urine

253

2217

1.39

2.55

4.0

4.1

—

(3014051) Protein [Presence] in Urine by Test strip

2.32

2.54

1.6

2.0

—

(3022621) pH of Urine by Test strip

204

1.79

2.51

1.6

2.4

—

(3023520) Reticulocytes [#/volume] in Blood

244

1.71

2.46

1.8

3.0

65.64

69.27

e9/l

0.35

186

(40761535) Cells panel - Urine sediment

244

1.66

2.20

3.0

3.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

209

0.42

2.14

1.2

1.3

—

(3013512) EKG study

112

880

1.38

2.13

5.0

3.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

321

2966

1.44

2.13

4.9

4.5

1.93

2.27

mu/l

0.39

298

2701

(36660697) Celiac disease serology panel - Serum

277

1.58

1.94

1.3

1.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

270

2443

1.33

1.90

6.7

7.4

70.02

79.12

u/l

5.83

259

2300

(4062490) Immunoglobulin typing, IgG

2.68

1.87

1.4

1.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

339

1.51

1.84

1.9

3.0

1.50

1.75

1.97

314

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

544

1.40

1.72

1.1

1.3

12.54

32.59

iu/ml

3.83

180

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

1.71

0.0

2.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

380

3677

1.94

1.68

18.8

19.5

40.56

40.46

0.13

361

3459

(3008295) Osmolality of Serum or Plasma

2.54

1.67

1.6

1.5

290.90

278.97

mosm/kgh2o

—

(3024731) MCV [Entitic volume]

380

3679

1.93

1.64

18.9

19.2

90.74

90.62

0.20

375

3629

(3022145) Colonoscopy Study observation

340

1.47

1.63

1.2

1.3

—

(3035941) MCH [Entitic mass]

380

3680

1.92

1.62

18.9

19.2

30.29

30.22

0.39

375

3629

(3026361) Erythrocytes [#/volume] in Blood

380

3681

1.91

1.61

18.9

19.3

4.53

4.52

e12/l

0.10

371

3581

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

241

2174

1.28

1.59

3.2

41.21

45.21

u/l

0.62

234

2037

(3035320) C reactive protein [Mass/volume] in Body fluid

3.03

1.58

1.7

1.8

—

(3010813) Leukocytes [#/volume] in Blood

380

3683

1.89

1.57

18.9

19.3

6.57

6.65

e9/l

0.35

370

3581

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

175

1521

1.27

1.56

5.3

7.2

1.22

mmol/l

0.86

148

1305

(3000963) Hemoglobin [Mass/volume] in Blood

380

3684

1.89

1.55

19.0

19.4

136.81

135.99

g/l

0.57

375

3631

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

1.53

0.0

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

3.36

1.53

1.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

3.36

1.53

1.0

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

0.00

1.50

0.0

2.8

—

0.95

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1.84

1.49

1.6

1.5

—

(3045414) Leukocytes [Presence] in Urine

133

1.69

1.46

1.5

1.7

—

(3007461) Platelets [#/volume] in Blood

379

3677

1.81

1.46

19.0

19.3

245.68

250.71

e9/l

0.95

370

3587

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

308

2883

1.31

1.43

5.3

5.5

38.94

39.46

mmol/mol

0.52

279

2682

(3025468) Yersinia sp identified in Specimen by Organism specific culture

2.28

1.41

1.1

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

2.28

1.41

1.1

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

2.22

1.38

1.1

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

2.22

1.38

1.1

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

2.22

1.38

1.1

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

2.22

1.38

1.1

1.5

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

2.63

1.37

1.2

1.3

2.08

1.77

mmol/l

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

323

3050

1.33

1.36

10.5

12.0

86.51

84.66

ml/min/173m2

0.82

276

2476

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

217

1.52

1.35

1.2

103.66

119.00

iu/ml

0.14

(4034850) Laboratory test

1.77

1.33

5.9

10.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

172

1517

1.24

1.29

2.2

2.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.80

1.29

1.0

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.80

1.29

1.0

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

358

1.39

1.26

4.5

6.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

714

1.28

1.20

3.5

3.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

117

1.66

1.20

1.5

1.8

—

(3000991) Gas panel - Venous blood

258

1.44

1.19

2.4

9.7

—

(3009261) Glucose [Presence] in Urine by Test strip

182

1627

1.22

1.17

3.2

3.5

0.00

estimate

-0.00

312

(3035637) Corticotropin [Mass/volume] in Plasma

2.07

1.16

1.5

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

507

1.31

1.15

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

812

1.26

1.14

1.4

1.3

4.27

1.27

u/ml

0.43

212

(3044640) Blood type and Crossmatch panel - Blood

119

1027

1.23

1.06

2.0

2.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

136

1190

1.22

1.06

1.8

1.9

95.60

95.76

pmol/l

0.01

616

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

2.14

1.06

1.1

1.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

138

1.55

1.05

2.0

2.9

0.64

0.67

0.19

138

(3019150) Specific gravity of Urine by Refractometry

708

1.26

1.05

3.4

3.6

1.02

kg/l

0.82

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

124

1.56

0.98

1.5

2.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

322

3076

1.26

0.97

4.6

4.3

5.84

5.89

mmol/l

0.32

300

2807

(42529406) Shigella sp [Presence] in Stool by Culture

118

0.50

0.95

1.3

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.95

0.0

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

2.16

0.92

1.2

1.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.71

0.89

1.3

1.4

—

(3013115) Eosinophils [#/volume] in Blood

183

1668

1.18

0.89

5.9

6.2

0.16

0.19

e9/l

1.37

168

1486

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

536

1.25

0.88

2.4

2.7

0.84

0.93

e6/l

0.16

295

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1.83

0.86

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

1.83

0.86

1.1

—

(1761868) Lipid panel - Serum or Plasma

105

1197

0.83

0.86

2.9

2.8

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

129

1.50

0.85

2.1

2.4

4365.50

4499.86

u/l

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

1.95

0.84

1.2

1.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

112

0.53

0.84

10.3

1.9

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

232

1.36

0.84

2.6

2.4

33.28

19.56

au/ml

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

114

0.52

0.84

1.0

1.1

—

(3020891) Body temperature

113

1.53

0.83

3.0

4.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

1.89

0.82

1.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

719

1.21

0.81

1.6

1.4

2.37

2.33

g/l

0.06

441

(1616796) Gas panel - Central venous blood

1.74

0.80

2.8

3.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

200

1.38

0.78

2.3

5.6

1.33

1.58

mmol/l

0.20

155

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

704

1.21

0.77

1.7

2.1

1.19

1.17

mg/l

0.03

545

(3008152) Bicarbonate [Moles/volume] in Arterial blood

166

1.41

0.77

4.3

9.9

24.86

24.98

mmol/l

0.08

157

(3029937) Albumin [Presence] in Urine by Test strip

100

876

1.19

0.76

3.5

3.7

0.00

estimate

0.50

314

(3000034) Microalbumin [Mass/volume] in Urine

0.00

0.76

0.0

3.2

—

19.21

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.76

0.0

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.56

0.76

1.5

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

184

1.38

0.76

1.0

—

(3045424) Erythrocytes [Presence] in Urine

1.71

0.76

1.6

1.3

—

(3015736) pH of Urine

143

1293

1.17

0.75

3.2

5.82

0.00

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

2.10

0.74

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

331

3196

1.22

0.74

4.8

4.7

2.71

2.75

mmol/l

0.45

304

2958

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1.86

0.74

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.86

0.74

1.0

1.4

—

nmol/l

—

(3044290) Cell count panel - Cerebral spinal fluid

1.64

0.72

1.2

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

429

1.24

0.72

2.0

1.7

1.47

1.48

0.03

384

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1.76

0.71

1.0

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

139

1258

1.16

0.71

3.3

3.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

532

1.22

0.71

1.8

1.7

1232.12

1128.14

nmol/l

0.40

398

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1.52

0.70

1.2

—

(3000494) Fungus identified in Specimen by Culture

384

0.76

0.70

1.3

1.4

—

(3011985) Renin [Units/volume] in Plasma

1.72

0.70

1.1

41.10

52.01

mu/l

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

339

1.27

0.70

4.3

4.8

230.27

240.98

u/l

0.36

323

(40760892) CBC W Ordered Manual Differential panel - Blood

166

1525

1.15

0.69

5.4

6.5

—

(3006315) Basophils [#/volume] in Blood

175

1614

1.15

0.69

5.7

5.9

0.04

e9/l

0.79

155

1416

(3047181) Lactate [Moles/volume] in Blood

1.58

0.69

3.0

12.5

1.40

1.14

mmol/l

0.44

(3014765) Yersinia sp identified in Stool by Organism specific culture

116

0.60

0.69

1.3

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

102

1.49

0.68

1.7

1.4

0.10

0.01

iu/ml

—

(3021788) Differential panel - Synovial fluid

1.64

0.67

1.3

1.4

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1.64

0.67

1.0

1.4

0.41

0.48

nmol/l

—

(3021960) Folate [Moles/volume] in Serum or Plasma

724

0.83

0.66

1.5

19.16

20.70

nmol/l

0.46

615

(3026493) Urate [Moles/volume] in Serum or Plasma

787

0.84

0.66

2.3

2.8

334.10

6011.70

umol/l

2.85

688

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

773

1.18

0.65

1.9

2.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

174

1610

1.14

0.65

4.2

4.7

0.00

estimate

-0.00

322

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

129

0.61

0.65

9.3

3.0

16.88

1423.75

u/ml

—

109

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

519

1.21

0.64

1.1

1.3

21.98

10.80

u/ml

0.33

213

(3020491) Glucose [Moles/volume] in Blood

1.73

0.64

1.2

2.0

7.68

6.28

mmol/l

—

(3028707) Methadone [Presence] in Urine by Screen method

1.54

0.63

1.3

1.8

—

(3001604) Monocytes [#/volume] in Blood

174

1613

1.14

0.63

5.7

5.9

0.56

0.58

e9/l

0.48

154

1412

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

176

1633

1.14

0.63

5.6

6.5

10.96

11.52

umol/l

0.16

170

1557

(3013139) Helicobacter pylori Ag [Presence] in Stool

191

1.33

0.62

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

325

3147

1.19

0.62

4.3

4.2

4.65

4.64

mmol/l

0.04

300

2930

(3023511) Choriogonadotropin [Units/volume] in Urine

1.49

0.61

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.3

—

19.14

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.60

0.0

1.2

—

(3000330) Specific gravity of Urine by Test strip

157

1.36

0.60

3.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.60

0.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

722

1.17

0.60

1.9

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1.55

0.60

6.0

5.3

398.63

371.69

umol/l

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1.52

0.58

1.0

1.1

—

20.00

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.58

0.0

3.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.58

0.0

4.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

0.57

1.6

1.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.46

0.56

1.3

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1.46

0.56

1.1

1.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

200

1881

1.13

0.56

8.5

9.2

3.84

4.07

e9/l

0.66

180

1653

(3004588) Protein electrophoresis panel - Serum or Plasma

194

0.71

0.56

6.2

2.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1.59

0.54

1.3

1.2

—

(3030467) Casts [#/volume] in Urine by Automated count

883

1.15

0.53

3.1

3.0

0.30

0.44

e6/l

0.40

654

(3035350) Ketones [Presence] in Urine by Test strip

172

1607

1.12

0.53

3.3

3.5

0.00

estimate

0.50

341

(3044889) 12 lead EKG panel

209

2204

0.89

0.53

3.8

3.6

—

(3037121) Protein [Mass/volume] in Urine

117

1.38

0.53

6.1

3.5

0.17

0.32

g/l

—

(3019198) Lymphocytes [#/volume] in Blood

178

1667

1.12

0.53

5.7

5.9

1.83

1.97

e9/l

0.83

164

1501

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

854

0.86

0.52

1.6

1.7

1.28

1.36

mmol/l

0.55

719

(3004616) Nuclear Ab [Presence] in Serum

1.51

0.52

1.7

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

312

3025

1.15

0.51

4.0

3.8

1.28

1.26

mmol/l

0.17

282

2796

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

322

3129

1.16

0.51

4.3

4.2

1.49

1.47

mmol/l

0.40

295

2898

(3002256) Pathology report gross observation

388

0.81

0.51

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

238

2271

1.12

0.50

3.1

3.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

249

2384

1.12

0.49

3.9

4.0

10.86

11.29

mm/h

0.19

232

2190

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

263

1.24

0.49

2.2

2.0

—

(3021901) Oxygen saturation in Capillary blood

1.50

0.48

2.1

3.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

121

1116

1.12

0.46

3.6

3.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

265

1.23

0.46

1.8

8.3

1.48

1.29

mmol/l

0.51

258

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.61

0.46

1.0

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1.44

0.46

1.0

1.1

1.68

1.38

g/l

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

156

1.30

0.46

2.3

2.6

0.07

0.12

e6/l

0.46

151

(3015377) Calcium [Moles/volume] in Serum or Plasma

110

1010

1.12

0.45

3.6

3.2

2.37

2.35

mmol/l

1.18

894

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

350

0.81

0.45

1.6

1.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

112

1.35

0.45

1.4

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.38

0.44

1.2

1.1

—

(36304419) Bacteria [Presence] in Urine

866

1.13

0.44

3.0

2.9

—

(40768443) Skin Pathology biopsy report

122

1.32

0.43

1.0

1.2

—

(3018010) Neutrophils/100 leukocytes in Blood

165

1555

1.11

0.42

5.1

5.9

56.34

56.94

0.27

150

1474

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

213

1.24

0.42

2.3

1.9

—

(40761536) Microorganisms panel - Urine sediment

282

0.80

0.42

3.0

3.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.41

0.0

3.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.41

0.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

0.41

0.0

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.41

0.0

3.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

3.2

—

35.91

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

6.3

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.41

0.0

2.6

—

780.25

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.40

0.0

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

193

0.77

0.40

1.9

1.5

—

(3023368) Bacteria identified in Blood by Culture

804

1.12

0.40

2.9

4.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1.32

0.39

1.3

1.4

—

(3023410) Appearance of Cerebral spinal fluid

1.43

0.39

1.0

1.8

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

0.39

0.0

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

0.00

0.39

0.0

24.7

—

6.54

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

139

1304

1.10

0.39

2.4

2.3

74.54

75.96

nmol/l

0.25

126

1164

(21494755) Public health laboratory ask at order entry panel

332

0.83

0.38

1.3

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

147

0.74

0.38

1.2

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

111

0.71

0.37

2.3

1.8

—

(3044941) Cell count panel - Synovial fluid

1.36

0.37

1.2

1.4

—

(3002030) Lymphocytes/100 leukocytes in Blood

166

1574

1.09

0.37

5.2

6.1

28.61

28.31

0.14

151

1489

(3037522) Nuclear Ab [Titer] in Serum

434

1.15

0.36

1.4

1.3

348.00

524.04

titre

—

(3035285) Chloride [Moles/volume] in Venous blood

1.37

0.34

2.0

2.6

106.83

105.64

mmol/l

—

(3041354) Potassium [Moles/volume] in Venous blood

1.37

0.34

2.0

2.6

3.98

4.02

mmol/l

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.37

0.34

2.0

2.6

—

(3006504) Eosinophils/100 leukocytes in Blood

160

1519

1.09

0.34

5.1

6.0

2.67

2.78

0.26

144

1431

(3025941) Bacteria identified in Stool by Culture

210

0.80

0.34

1.1

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

423

0.86

0.34

1.7

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

118

1.28

0.34

1.6

296.13

307.20

mu/l

0.09

109

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

351

1.16

0.33

2.0

1.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.69

0.33

1.7

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

110

1.28

0.32

1.3

1.8

—

256.00

—

(3002385) Erythrocyte distribution width [Ratio]

300

2931

1.10

0.32

14.0

15.8

15.44

14.68

1.04

290

2893

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.71

0.31

1.6

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.71

0.31

1.6

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.71

0.31

1.6

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.71

0.31

1.6

1.5

—

(3024928) Oxygen saturation in Venous blood

1.33

0.31

1.7

4.2

—

(3002582) Erythrocytes [#/volume] in Urine

104

973

1.09

0.31

3.2

3.0

121.82

109.93

e6/l

0.05

740

(3018572) Chloride [Moles/volume] in Blood

1.30

0.30

4.0

15.3

105.71

104.85

mmol/l

—

(3039000) Anion gap in Blood

1.30

0.30

4.0

15.3

11.57

11.02

mmol/l

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

345

0.86

0.30

1.5

1.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

393

1.13

0.29

1.4

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.25

0.29

1.1

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.25

0.29

1.3

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

106

0.75

0.29

1.5

1.6

—

(3019069) Monocytes/100 leukocytes in Blood

160

1528

1.08

0.29

5.3

6.3

8.60

8.50

0.15

144

1442

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.28

0.28

1.4

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

467

0.89

0.27

2.5

2.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

134

1407

0.93

0.27

2.7

2.6

148.35

118.18

ug/l

0.25

122

1285

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

309

0.86

0.26

1.9

2.3

24.76

31.59

u/l

1.26

263

(3023183) Ammonium ion [Moles/volume] in Plasma

0.70

0.26

2.0

4.1

40.20

36.11

umol/l

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.69

0.26

1.2

6.4

—

496.42

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.68

0.26

1.0

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

445

1.12

0.26

1.8

2.2

2.51

2.35

g/l

1.22

412

(3022096) Basophils/100 leukocytes in Blood

153

1467

1.07

0.25

5.2

6.1

0.62

0.67

0.49

139

1379

(3018095) Leukocytes [#/volume] in Urine

118

1121

1.08

0.24

3.9

3.6

22.40

84.40

e6/l

2.77

784

(3005033) Fetal Nuchal fold Thickness US

0.72

0.24

1.7

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.72

0.24

1.7

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

933

0.93

0.23

2.6

3.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

546

1.09

0.23

4.0

2.9

2.44

2.45

mmol/l

0.18

476

(1002224) Polysomnography panel

146

0.82

0.22

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

146

0.82

0.22

1.3

1.6

—

(4035726) Immunohistochemistry procedure

262

0.87

0.22

1.2

1.4

—

(3025130) Human papilloma virus identified in Specimen

1.19

0.21

1.8

1.9

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

0.21

0.0

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.00

0.21

0.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

0.00

0.21

0.0

1.2

—

(3034426) Prothrombin time (PT)

0.00

0.21

0.0

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

103

0.77

0.21

2.5

5.7

1.01

1.39

mg/l

—

(3024471) HLA-A [Type]

0.00

0.21

0.0

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.21

0.0

6.7

—

(3035880) pH of Pleural fluid

0.00

0.21

0.0

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.6

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.21

0.0

3.3

—

(3024932) HLA-DR beta [Type]

0.00

0.21

0.0

1.2

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

0.21

0.0

5.1

—

48.21

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

375

0.90

0.20

2.9

7.1

104.38

103.83

mmol/l

0.33

375

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

540

0.92

0.20

2.6

3.0

0.76

0.78

ug/l

0.03

352

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

581

0.92

0.20

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.00

0.20

0.0

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.00

0.20

0.0

1.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

250

1.13

0.20

1.9

2.4

6.08

6.13

ug/l

0.01

217

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1.23

0.20

1.7

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

312

0.89

0.20

3.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1.18

0.19

1.0

1.8

—

(3020779) Urea [Moles/volume] in Serum or Plasma

251

1.12

0.19

2.3

7.8

6.47

8.80

mmol/l

3.12

242

(3039443) Prostate specific Ag panel - Serum or Plasma

1.16

0.19

1.2

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

109

1.20

0.19

1.5

1.6

—

(3022313) Gas panel - Capillary blood

166

1.15

0.18

2.3

5.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.19

0.18

1.0

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

215

0.88

0.17

1.7

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

244

1.11

0.16

1.7

3.7

1.23

mmol/l

0.09

213

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.16

0.16

1.5

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1.13

0.16

1.1

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.79

0.15

1.8

1.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

420

1.08

0.15

1.9

2.3

22.88

23.23

0.07

364

(3019832) Treponema pallidum Ab [Presence] in Serum

389

0.92

0.15

1.9

1.8

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

0.81

0.14

11.4

3.0

—

2.92

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.80

0.14

1.4

1.8

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

0.80

0.14

11.6

3.1

42.70

28.54

mg/l

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

0.80

0.14

11.6

3.1

58.13

132.43

mg/l

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

150

1.14

0.14

2.5

6.1

24.64

24.97

mmol/l

0.26

144

(3018418) pH of Serum or Plasma

937

0.95

0.14

4.5

3.7

7.39

7.40

0.37

172

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

914

1.05

0.14

5.0

4.8

2.21

2.49

ug/l

0.19

819

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.20

0.14

1.9

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

0.83

0.14

2.6

—

(3052851) Hemolysis interference index of Serum or Plasma

0.83

0.14

2.6

3.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.81

0.14

1.8

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

180

1.12

0.13

1.5

1.3

—

(40758558) Short blood count panel - Blood

807

1.05

0.13

7.7

6.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

152

1.12

0.12

2.2

2.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

710

0.95

0.12

1.8

2.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

504

1.06

0.11

2.6

2.9

4.12

2.40

e6/l

0.49

267

(3028300) Cannabinoids [Presence] in Urine

177

0.90

0.10

1.4

1.5

—

(3027008) Opiates [Presence] in Urine

177

0.90

0.10

1.4

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1.11

0.10

1.0

1.2

—

(3023419) Bacteria identified in Sputum by Culture

1.11

0.10

2.0

2.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1.09

0.09

1.8

1.1

—

(3027944) Amphetamines [Presence] in Urine

176

0.91

0.09

1.4

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

176

0.91

0.09

1.4

1.5

—

(3019230) Fractional oxyhemoglobin in Venous blood

1.06

0.09

1.2

3.3

49.00

64.85

—

(3042936) Bacteria identified in Isolate by Culture

451

0.95

0.09

1.8

2.0

—

(3026008) Bacteria identified in Urine by Culture

954

1.04

0.09

3.0

2.8

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1.11

0.09

1.0

1.1

—

2.99

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

134

0.89

0.09

1.4

2.0

—

(4200892) Spirometry reversibility

224

1.08

0.08

1.4

—

(3008898) HLA-B27 [Presence]

146

1.10

0.08

1.2

1.1

—

(40768800) Prostate Pathology biopsy report

0.83

0.08

1.0

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.07

0.07

1.6

1.9

—

(40768797) Stomach Pathology biopsy report

432

1.05

0.07

1.3

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1.03

0.07

1.4

1.1

—

35.64

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.05

0.07

1.8

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

0.88

0.07

1.4

1.2

—

3.62

—

(3007853) Bacteria identified in Skin by Aerobe culture

354

1.05

0.07

1.4

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

0.87

0.07

1.4

1.2

—

7.44

—

(3007566) Smooth muscle Ab [Titer] in Serum

0.85

0.06

1.1

1.3

—

56.67

—

(3012516) Albumin [Mass/volume] in Urine

850

1.03

0.06

3.4

3.3

20.21

213.24

mg/l

1.13

558

(3003396) Base excess in Arterial blood by calculation

325

0.95

0.06

2.8

9.8

1.22

1.18

mmol/l

0.03

270

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

152

0.92

0.06

3.1

14.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

121

0.91

0.06

1.4

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

237

1.06

0.06

3.7

2.7

63.33

66.32

ml/min/173m2

—

104

(3021879) Hepatitis B virus core Ab [Presence] in Serum

263

0.95

0.05

1.7

1.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

485

0.96

0.05

2.0

2.2

13.79

13.30

umol/l

0.23

452

(3000492) Spirometry study

322

0.96

0.04

1.2

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

1.10

0.04

3.6

3.9

—

(3020682) Albumin/Creatinine [Ratio] in Urine

896

1.02

0.04

3.7

3.9

2.84

9.97

mg/mmol

3.12

574

(3024561) Albumin [Mass/volume] in Serum or Plasma

130

1285

1.02

0.04

4.9

4.8

35.77

35.90

g/l

0.12

122

1204

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

498

1.03

0.03

1.5

1.9

—

(3001019) Free T4 and TSH panel - Serum or Plasma

151

1.06

0.03

1.4

1.7

—

(40768804) Tissue Pathology biopsy report

127

1284

0.98

0.03

2.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

732

0.98

0.03

4.1

4.3

20.63

21.45

0.21

345

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

181

1.05

0.03

1.2

1.7

—

(3049717) Cytology report of Urine Cyto stain

112

1.07

0.03

3.3

2.8

—

(3021589) Normoblasts [#/volume] in Blood

149

1500

0.99

0.02

8.0

9.1

0.00

e9/l

0.55

123

1238

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

739

0.99

0.02

2.0

2.38

3.02

mg/l

3.26

639

(3050129) First trimester maternal screen panel - Serum or Plasma

133

1.05

0.01

1.8

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

217

0.97

0.01

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

968

0.99

0.01

3.1

8.44

7.71

mmol/l

0.77

824

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

307

0.98

0.01

1.9

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

626

0.99

0.00

1.7

414.59

440.20

pmol/l

0.47

531

(3003694) ABO and Rh group [Type] in Blood

946

0.99

0.00

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.02

0.00

1.3

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

589

1.00

0.00

3.6

3.7

13.56

347.75

ng/l

2.39

434

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

829

1.00

0.00

2.5

3.3

539.24

1118.95

ng/l

3.90

699

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

117

1.03

0.00

1.7

2.2

—

(3011288) Drugs identified in Urine by Screen method

127

1.02

0.00

1.6

1.8

—

(3016879) Cocaine [Presence] in Urine

163

0.98

0.00

1.4

1.6

—

(3019060) Gas panel - Arterial blood

177

1.02

0.00

3.3

7.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

264

0.98

0.00

2.8

10.5

128.19

121.99

g/l

0.68

258

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

506

1.01

0.00

2.4

2.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.95

-0.00

7.2

3.5

—

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.00

-0.00

0.0

6.1

—

(3002619) Bacteria identified in Specimen by Culture

0.00

-0.00

0.0

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

-0.00

0.0

5.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1.00

-0.00

2.0

6.9

9.69

8.63

kpa

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

-0.00

0.0

1.2

—

(3019174) dRVVT (LA screen)

0.00

-0.00

0.0

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

21.82

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

-0.00

0.0

7.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

-0.00

0.0

1.2

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

0.00

-0.00

0.0

2.2

—

3703.40

—

(3014891) Appearance of Pleural fluid

0.00

-0.00

0.0

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.6

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.3

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

(3042733) HLA Ab [Presence] in Serum

0.00

-0.00

0.0

2.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.00

-0.00

0.0

9.5

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

-0.00

0.0

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

0.00

-0.00

0.0

1.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

0.00

-0.00

0.0

1.7

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

3.56

—

(3001186) Copper [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

16.42

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.00

-0.00

0.0

4.0

—

7.15

—

(3052592) Norovirus Ag [Presence] in Stool

0.00

-0.00

0.0

1.4

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

7.06

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

6.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

0.95

-0.00

1.0

1.2

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.99

-0.00

1.0

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

41.88

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.4

—

44.00

—

(40757373) Influenza virus identified in Isolate

0.00

-0.00

0.0

1.4

—

(3033799) Differential panel - Peritoneal fluid

0.00

-0.00

0.0

1.3

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.7

—

4.84

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.9

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.92

-0.00

1.4

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.00

-0.00

0.0

9.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.00

-0.00

0.0

1.3

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_CONTACT_W_VENOMO_SNAKES_LIZAR – Contact with venomous snakes and lizards

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Contact with venomous snakes and lizards

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Contact with venomous snakes and lizards (VWXY20_CONTACT_W_VENOMO_SNAKES_LIZAR)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints